BIOTECH ASSISTANT / FIELD NOTES

Microcrystal electron diffraction in macromolecular and pharmaceutical structure determination

Academic source · Drug Discovery Today: Technologies

Source published:

Site published: 2026-11-03 · Updated: 2026-11-03

Explore this article with AI

This source is linked automatically. Choose a question to get started.

Ask AI ↗

What the paper reports

Clabbers and Xu review the properties of electron diffraction and early MicroED developments relevant to pharmaceutical chemistry and structural biology. The discussion spans small-molecule structure determination, fragment screening, and structure-guided discovery. It is a historical perspective on opportunities and limitations, rather than new experimental proof of performance across a pharmaceutical sample collection.

Why this paper is included

An early pharmaceutical-facing review that helps explain why MicroED complements existing structural methods rather than replacing every crystallographic approach.

The interpretation above is analysis, not a conclusion attributed to the original source.

Read the original source ↗

Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections

MicroED structure determination

Related updates

Biotech Assistant · Original commentary · Blog / commentary

How MicroED is Transforming Drug Polymorph Research Workflow

This article explores how Microcrystal Electron Diffraction (MicroED) is set to revolutionize drug polymorph research workflows. Drawing upon recent news, official websites, and LinkedIn updates from Crystal Pharmatech and Eldico, it clearly distinguishes between verified facts, industry viewpoints, and information pending verification.

Continue your research

Explore company filters, side-by-side comparisons, private bookmarks, and member discussions.

Open free member tools ↗
AI assistant ↗